Marinus Pharma CS
(MRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,664 | -34,730 | -19,816 | 14,496 | -58,794 |
| Depreciation Amortization | -120 | -4 | 1,029 | 469 | 315 |
| Other Working Capital | -9,960 | -12,136 | -6,092 | -12,367 | -12,502 |
| Other Operating Activity | 10,908 | 5,392 | -88,007 | -93,570 | 9,654 |
| Operating Cash Flow | $-65,836 | $-41,478 | $-112,886 | $-90,972 | $-61,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -46,995 | -51,995 | N/A | N/A | N/A |
| PPE Investments | N/A | N/A | -1,603 | -1,682 | -421 |
| Net Acquisitions | N/A | N/A | 107,375 | 107,375 | N/A |
| Other Investing Activity | 4 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-46,991 | $-51,995 | $105,772 | $105,693 | $-421 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 28,588 | 28,838 | 29,400 |
| Debt Issued | N/A | N/A | 29,921 | N/A | N/A |
| Common Stock Issued | 484 | N/A | 66,271 | 1,763 | 1,747 |
| Other Financing Activity | -421 | -174 | -42 | 0 | 0 |
| Financing Cash Flow | $63 | $-174 | $124,738 | $30,601 | $31,147 |
| Beginning Cash Position | 240,551 | 240,551 | 122,927 | 122,927 | 122,927 |
| End Cash Position | 127,787 | 146,904 | 240,551 | 168,249 | 92,326 |
| Net Cash Flow | $-112,764 | $-93,647 | $117,624 | $45,322 | $-30,601 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,836 | -41,478 | -112,886 | -90,972 | -61,327 |
| Capital Expenditure | N/A | N/A | -1,774 | -1,682 | -421 |
| Free Cash Flow | -65,836 | -41,478 | -114,660 | -92,654 | -61,748 |